Solution structure of a conserved C-terminal domain of p73 with structural homology to the SAM domain

EMBO Journal

Volumn 18, Issue 16, 1999, Pages 4438-4445

  Chi, Seung Wook ^a   Ayed, Ayeda ^a   Arrowsmith, Cheryl H ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

NMR spectroscopy; p53; SAM domain; Tumor suppressor

Indexed keywords

PROTEIN P73; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; SEQUENCE HOMOLOGY; TUMOR SUPPRESSOR GENE;

AMINO ACID SEQUENCE; CONSERVED SEQUENCE; DNA-BINDING PROTEINS; FETAL PROTEINS; GENES, TUMOR SUPPRESSOR; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; NUCLEAR PROTEINS; PROTEIN FOLDING; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, EPHA4; RECEPTOR, EPHB2; SEQUENCE HOMOLOGY, AMINO ACID; SOLUTIONS; TUMOR SUPPRESSOR PROTEINS;

EID: 0033575719     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/18.16.4438     Document Type: Article

References (62)

1. Almog, N. and Rotter, V. (1998) An insight into the life of p53: a protein coping with many functions! Review of the 9th p53 Workshop, Crete, May 9-13, 1998. Biochim. Biophys. Acta, 1378, R43-R54.
2. Bork, P. and Koonin, E.V. (1998) Predicting functions from protein sequences - where are the bottlenecks? Nature Genet., 18, 313-318.
3. Brünger, A.T. (1996) X-PLOR (Version 3.843): A System for X-ray Crystallography and NMR. Yale University Press, New Haven, CT.
4. Cross, S.M., Sanchez, C.A., Morgan, C.A., Schimke, M.K., Ramel, S., Idzerda, R.L., Raskind, W.H. and Reid, B.J. (1995) A p53-dependent mouse spindle checkpoint. Science, 267, 1353-1356.
5. Davison, T.D., Vagner, C., Kaghad, M., Ayed, A., Caput, D. and Arrowsmith, C.H. (1999) p73 and p63 are homo-tetramers capable of weak hetero-typic interactions with each other but not with p53. J. Biol. Chem., 274, 18709-18714.
6. De Laurenzi, V., Costanzo, A., Barcaroli, D., Terrinoni, A., Falco, M., Annicchiarico-Petruzzelli, M., Levrero, M. and Melino, G. (1998) Two new p73 splice variants, gamma and delta, with different transcriptional activity. J. Exp. Med., 188, 1763-1768.
7. Delaglio, F., Grzesiek, S., Vuister, G.W., Zhu, G., Pfeifer, J. and Bax, A. (1995) NMRPipe: a multidimensional spectral processing system based on UNIX PIPES. J. Biomol. NMR, 6, 277-293.
8. Di Como, C.J. and Prives, C. (1998) Human tumor-derived p53 proteins exhibit binding site selectivity and temperature sensitivity for transactivation in a yeast-based assay. Oncogene, 16, 2527-2539.
9. Di Como, C.J., Gaiddon, C. and Prives, C. (1999) p73 function is inhibited by tumor-derived p53 mutants in mammalian cells. Mol. Cell. Biol., 19, 1438-1449.
10. Donehower, L.A. and Bradley, A. (1993) The tumor suppressor p53. Biochim. Biophys. Acta, 1155, 181-205.
11. Donehower, L.A., Harvey, M., Slagle, B.L., McArthur, M.J., Montgomery, C.A., Jr, Butel, J.S. and Bradley, A. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature, 356, 215-221.
12. Folmer, R., Hilbers, C., Konings, R. and Nilges, M. (1997) Floating stereospecific assignment revisited: application to an 18kDa protein and comparison with J coupling data. J. Biomol. NMR, 9, 245-258.
13. Golub, T.R. (1997) TEL gene rearrangements in myeloid malignancy. Hematol. Oncol. Clin. North Am., 11, 1207-1220.
14. Golub, T.R., Barker, G.F, Lovett, M. and Gilliland, D.G. (1994) Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell, 77, 307-316.
15. Graeber, T.G., Osmanian, C., Jacks, T., Housman, D.E., Koch, C.J., Lowe, S.W. and Giaccia, A.J. (1996) Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature, 379, 88-91.
16. Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C.C. (1991) p53 mutations in human cancer. Science, 253, 49-53.
17. Hollstein, M., Shomer, B., Greenblatt, M., Soussi, T., Hovig, E., Montesano, R. and Harris, C.C. (1996) Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res., 24, 141-146.
18. Holm, L. and Sander, C. (1993) Protein structure comparison by alignment of distance matrices. J. Mol. Biol., 233, 123-138.
19. Holm, L. and Sander, C. (1994) The FSSP database of structurally aligned protein fold families. Nucleic Acids Res., 22, 3600-3609.
20. Hupp, T.R., Meek, D.W., Midgley, C.A. and Lane, D.P. (1992) Regulation of the specific DNA binding function of p53. Cell, 71, 875-886.
21. Ishioka, C., Englert, C., Winge, P., Yan, Y.-X., Engelstein, M. and Friend, S.H. (1995) Mutational analysis of the carboxy-terminal portion of p53 using both yeast and mammalian cell assays in vivo. Oncogene, 10, 1485-1492.
22. Johnson, B.A. and Blevins, R.A. (1994) NMR VIEW - a computer program for the visualization and analysis of NMR Data. J. Biomol. NMR, 4, 603-614.
23. Johnson, M.L., Correia, J.J., Yphantis, D.A. and Halvorson, H.R. (1981) Analysis of data from the analytical ultracentrifuge by nonlinear least-squares techniques. Biophys. J., 36, 575-588.
24. Jost, C.A., Marin, M.C. and Kaelin, W.G., Jr (1997) p73 is a human p53-related protein that can induce apoptosis. Nature, 389, 191-194.
25. Jousset, C. et al. (1997) A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFR beta oncoprotein. EMBO J., 16, 69-82.
26. Kaghad, M. et al. (1997) Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other cancers. Cell, 90, 809-819.
27. Kastan, M.B., Onyekwere, O., Sidransky, D., Vogelstein, B. and Craig, R.W. (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51, 6304-6311.
28. Kastan, M.B., Zhan, Q., el-Deiry, W.S., Carrier, F., Jacks, T., Walsh, W.V., Plunkett, B.S., Vogelstein, B. and Fornace, A.J., Jr (1992) A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell, 71, 587-597.
29. Kay, L.E., Keifer, P. and Saarinen, T. (1992) Pure absorption gradient enhanced heteronuclear single quantum correlation spectroscopy with improved sensitivity. J. Am. Chem. Soc., 114, 10663-10665.
30. 2O saturation. J. Magn. Reson., A109, 129-133.
31. Ko, L.J. and Prives, C. (1996) p53: puzzle and paradigm. Genes Dev., 10, 1054-1072.
32. Kraulis, P.J. (1991) MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr., 24, 946-950.
33. Kyba, M. and Brock, H.W. (1998) The SAM domain of polyhomeotic, RAE28 and scm mediates specific interactions through conserved residues. Dev. Genet., 22, 74-84.
34. Laskowski, R., Rullman, J., MacArthur, M., Kaptein, R. and Thornton, J. (1996) AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR, 8, 477-486.
35. Lane, D.P. (1992) p53, guardian of the genome. Nature, 358, 15-16.
36. Levine, A.J. (1997) p53, the cellular gatekeeper for growth and division. Cell, 88, 323-331.
37. Malkin, D. et al. (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms. Science, 250, 1233-1238.
38. Merritt, E.A. and Murphy, M.E. (1994) Raster 3D version 2.0. A program for realistic molecular graphics. Acta Crystallogr., D50, 869-873.
39. Mills, A.A., Zheng, B., Wang, X.J., Vogel, H., Roop, D.R. and Bradley, A. (1999) p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature, 398, 708-713.
40. Morin, P.E., Awrey, D.E., Edwards, A.M. and Arrowsmith, C.H. (1996) Elongation factor TFIIS contains three structural domains: solution structure of domain II. Proc. Natl Acad. Sci. USA, 93, 10604-10608.
41. Nicholls, A., Sharp, K.A. and Honig, B. (1991) Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins, 11, 281-296.
42. Nilges, M. (1995) Calculation of protein structures with ambiguous distance restraints. Automated assignment of ambiguous NOE crosspeaks and disulphide connectivities. J. Mol. Biol., 245, 645-660.
43. Nilges, M., Macias, M., O'Donoghue, S. and Oschkinat, H. (1997) Automated NOESY interpretation with ambiguous distance restraints: the refined NMR solution structure of the pleckstrin homology domain from β-spectrin. J. Mol. Biol., 269, 408-422.
44. Osada, M. et al. (1998) Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nature Med., 4, 839-843.
45. Pavletich, N.P., Chambers, K.A. and Pabo, C.O. (1993) The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots. Genes Dev., 12, 2556-2564.
46. Peterson, A.J., Kyba, M., Bornemann, D., Morgan, K., Brock, H.W. and Simon, J. (1997) A domain shared by the Polycomb group proteins Scm and ph mediates heterotypic and homotypic interactions. Mol. Cell. Biol., 17, 6683-6692.
47. 1H NMR studies of human lysozyme: spectral assignment and comparison with hen lysozyme. Biochemistry, 29, 7201-7214.
48. Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
49. Schmale, H. and Bamberger, C. (1997) A novel protein with strong homology to the tumor suppressor p53. Oncogene, 15, 1363-1367.
50. Schultz, J., Ponting, C.P., Hofmann, K. and Bork, P. (1997) SAM as a protein interaction domain involved in developmental regulation. Protein Sci., 6, 249-253.
51. Slupsky, C.M., Gentile, L.N., Donaldson, L.W., Mackereth, C.D., Seidel, J.J., Graves, B.J. and McIntosh, L.P. (1998) Structure of the Ets-1 pointed domain and mitogen-activated protein kinase phosphorylation site. Proc. Natl Acad. Sci. USA, 95, 12129-12134.
52. Smalla, M., Schmieder, P., Kelly, M., terLaak, A., Krause, G., Ball, L., Wahl, M., Bork, P. and Oschkinat, H. (1999) Solution structure of the receptor tyrosine kinase EphB2 SAM domain and identification of two distinct homotypic interaction sites. Protein Sci., in press.
53. 1H NMR spin-spin coupling constants. Biochemistry, 30, 986-996.
54. Stapleton, D., Balan, I., Pawson, T. and Sicheri, F. (1999) The crystal structure of an Eph receptor SAM domain reveals a mechanism for modular dimerization. Nature Struct. Biol., 6, 44-49.
55. Thanos, C.D., Goodwill, K.E. and Bowie, J.U. (1999) Oligomeric structure of the human EphB2 receptor SAM domain. Science, 283, 833-836.
56. Trink, B., Okami, K., Wu, L., Sriuranpong, V., Jen, J. and Sidransky, D. (1998) A new human p53 homologue. Nature Med., 4, 747-748.
57. Vousden, K. (1993) Interactions of human papillomavirus transforming proteins with the products of tumor suppressor genes. FASEB J., 7, 872-879.
58. 1H nuclear magnetic resonance assignments from distance geometry calculations. J. Mol. Biol., 204, 483-487.
59. Wu, X., Bayle, J.H., Olson, D. and Levine, A.J. (1993) The p53-mdm2 autoregulatory feedback loop. Genes Dev., 7, 1126.
60. Yang, A., Kaghad, M., Wang, Y., Gillett, E., Fleming, M.D., Dotsch, V., Andrews, N.C., Caput, D. and McKeon, F. (1998) p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing and dominant-negative activities. Mol. Cell, 2, 305-316.
61. Yang, A. et al. (1999) p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature, 398, 714-718.
62. Zhu, J., Jiang, J., Zhou, W. and Chen, X. (1998) The potential tumor suppressor p73 differentially regulates cellular p53 target genes. Cancer Res., 58, 5061-5065.